Clincosm LogoSign in Get a demo

lymphoma

Showing NaN - NaN of 239
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Cancer, Solid Tumor, Lymphoma Trial in Canada, United States (Sym023)

Completed
Has Results
  • Metastatic Cancer
  • +2 more
  • Grand Rapids, Michigan
  • +3 more
Oct 11, 2021

Solid Tumor, Adult Trial in United States (LNS8801 -Small molecule, orally bioavailable, selective agonist of GPER,

Recruiting
  • Solid Tumor, Adult
  • Lymphoma
  • LNS8801 -Small molecule, orally bioavailable, selective agonist of GPER
  • Pembrolizumab - anti-PD-1 antibody
  • Los Angeles, California
  • +7 more
Oct 11, 2021

Lymphoma Trial in United States (ACTR707, rituximab)

Terminated
  • Lymphoma
  • ACTR707
  • rituximab
  • Gilbert, Arizona
  • +10 more
Oct 4, 2021

Cancer, Adult Solid Tumor, Lymphoma Trial in United States

Recruiting
  • Cancer
  • +3 more
    • Birmingham, Alabama
    • +39 more
    Sep 28, 2021

    Leukemia, Lymphoma Trial in Houston (other, behavioral, dietary supplement)

    Active, not recruiting
    • Leukemia
    • Lymphoma
    • Counseling
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 17, 2021

    Lymphoma Trial in Houston (AMG 531, Rituximab, Cyclophosphamide)

    Completed
    Has Results
    • Lymphoma
    • AMG 531
    • +8 more
    • Houston, Texas
      UT MD Anderson Cancer Center
    Aug 25, 2021

    After Whole Brain Radiation Therapy for Hematologic Malignancies

    Recruiting
    • Central Nervous System Lymphoma
    • +5 more
    • Magnetic Resonance Imaging
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 12, 2021

    Lymphoma Trial in Worldwide (immunoscintigraphy, technetium Tc 99m epratuzumab)

    Unknown status
    • Lymphoma
    • immunoscintigraphy
    • technetium Tc 99m epratuzumab
    • Los Angeles, California
    • +7 more
    Aug 12, 2021

    Lymphoma Trial in Worldwide (immunoscintigraphy, technetium Tc 99m epratuzumab)

    Unknown status
    • Lymphoma
    • immunoscintigraphy
    • technetium Tc 99m epratuzumab
    • Los Angeles, California
    • +7 more
    Aug 12, 2021

    B-Cell Non-Hodgkin Lymphoma, Hematopoietic and Lymphoid Cell Tumor, Leukemia Trial in Houston (Ipilimumab, Lenalidomide)

    Active, not recruiting
    • B-Cell Non-Hodgkin Lymphoma
    • +5 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 6, 2021

    Solid Tumor, Lymphoma Trial in Korea, Republic of, United States (IMC-002)

    Recruiting
    • Solid Tumor
    • Lymphoma
    • IMC-002
    • Saint Louis, Missouri
    • +3 more
    Jun 29, 2021

    Metastatic Solid Tumor, Lymphoma Trial in United States (SYNB1891, Atezolizumab)

    Recruiting
    • Metastatic Solid Neoplasm
    • Lymphoma
    • Aurora, Colorado
    • +3 more
    May 11, 2021

    FLT-PET/CT vs FDG-PET/CT for Therapy Monitoring of Diffuse Large

    Completed
    • Lymphoma
    • +2 more
    • FLT-PET/CT
    • +2 more
    • Los Angeles, California
    • +3 more
    May 6, 2021

    Lymphoma, Relapsed Lymphoma, Refractory Lymphoma Trial in United States (fimepinostat, Rituximab, venetoclax)

    Completed
    • Lymphoma
    • +10 more
    • Los Angeles, California
    • +10 more
    May 5, 2021

    Leukemia, Lymphoma Trial in Houston (HSCT, DLI)

    Completed
    • Leukemia
    • Lymphoma
    • HSCT
    • DLI
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Mar 9, 2021

    Advanced Solid Tumors, Carcinoid, Colorectal Cancer Trial in Poland, Spain, United States (Modified FOLFOX6, Conatumumab,

    Completed
    Has Results
    • Advanced Solid Tumors
    • +8 more
    • Modified FOLFOX6
    • +3 more
    • Duarte, California
    • +11 more
    Feb 3, 2021

    Metastatic Cancer, Solid Tumor, Lymphoma Trial in Grand Rapids, Houston, Toronto (Sym022)

    Completed
    Has Results
    • Metastatic Cancer
    • +2 more
    • Grand Rapids, Michigan
    • +2 more
    Feb 1, 2021

    Diffuse Large Cell Lymphoma, Lymphoma Trial in Houston (Zevalin, Carmustine, Etoposide)

    Completed
    Has Results
    • Diffuse Large Cell Lymphoma
    • Lymphoma
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Jan 12, 2021

    Bone Sarcoma, Femur Fracture, Lymphoma Trial in Houston (Dalteparin)

    Completed
    Has Results
    • Bone Sarcoma
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 31, 2020

    Leukemia, Lymphoma Trial in Houston (drug, radiation, procedure)

    Completed
    • Leukemia
    • Lymphoma
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Jan 6, 2021

    Lymphoma, Leukemia, Multiple Myeloma Trial in Australia, Germany, United States (LBH589)

    Completed
    Has Results
    • Lymphoma
    • +2 more
    • Augusta, Georgia
    • +6 more
    Dec 16, 2020

    Cognitive Training in Attenuating Attention Deficits/Child

    Active, not recruiting
    • Leukemia
    • +2 more
    • Cognitive Training Program
    • Control Group
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Dec 29, 2020

    Lymphoma, Disorder Related to Bone Marrow Transplantation Trial in Houston (Fludarabine, Melphalan, Allogeneic Transplant)

    Completed
    Has Results
    • Lymphoma
    • Disorder Related to Bone Marrow Transplantation
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Dec 3, 2020

    Leukemia, Lymphoma Trial in Houston (Actonel (Risedronate), Calcium, Vitamin D)

    Completed
    Has Results
    • Leukemia
    • Lymphoma
    • Actonel (Risedronate)
    • +2 more
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Dec 2, 2020

    Advanced Solid Tumor, Lymphoma Trial in United States (Milademetan)

    Completed
    • Advanced Solid Tumor
    • Lymphoma
    • Detroit, Michigan
    • +4 more
    Dec 4, 2020